RxDoctor Payments Data

James Hsieh

Medical Oncology · Saint Louis, MONPI 1205854924

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,700 of the $10,110 with a category attached, or 86.1%. Every reported general payment came from a single manufacturer, Eisai Inc.. Reporting peaked in 2019 at $6,985 and has fallen 77.6% since, to $1,563 in 2021.

$10,110in general payments, 2019–2025

Across 12 payments — averaging $842.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$10K
$3,841,781in research payments, 2019–2025

Across 273 payments — averaging $14,072 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$2M
  • E.r. Squibb & Sons, L.L.C.$941K
  • Eisai Inc.$483K
  • Exelixis Inc.$437K
  • AstraZeneca$29K

What the payments were for

  • Consulting fees$8,70086%
  • Travel & lodging$1,28913%
  • Food & beverage$1211%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.12$10,110

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,110 in reported general payments places this provider in the 60th percentile of 144 medical oncology providers in Missouri.

See all medical oncology providers in Missouri →

Other medical oncology in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →